
Nike (NKE) is among several companies, including Concentrix (CNXC), American Outdoor Brands (AOUT), and Aethlon Medical (AEMD), scheduled to report earnings after hours on June 26, 2025. NKE's consensus EPS for the quarter ending May 31, 2025, is $0.12, representing an 88.12% year-over-year decrease. This expected decline contrasts with Nike's consistent track record of beating earnings estimates over the past year and its 2025 P/E ratio of 28.43, which significantly exceeds the industry average of 16.50, implying robust future growth expectations despite the near-term EPS forecast.
Upcoming earnings reports reveal starkly different profiles for four key companies. Nike, Inc. (NKE) faces a critical test, with analysts forecasting a severe 88.12% year-over-year decline in EPS to $0.12. This negative outlook is in direct conflict with both its consistent history of beating quarterly expectations and its premium 2025 P/E ratio of 28.43, which is well above the industry average of 16.50 and implies strong future growth expectations. In contrast, Concentrix Corporation (CNXC) presents a value or distress scenario; despite a forecast for modest 2.46% YoY EPS growth, it carries a low P/E of 5.33 versus its industry's 24.40 and has significant short interest, indicated by a "days to cover" ratio exceeding 10. American Outdoor Brands, Inc. (AOUT) shows a notable disconnect between valuation and performance, with a premium P/E of 26.66 against an industry average of 10.10, despite forecasting another quarterly loss ($-0.07) and having a recent history of substantially missing earnings by -60%. Finally, Aethlon Medical, Inc. (AEMD) appears to be a speculative turnaround story, with a forecasted 86.54% YoY improvement in its loss per share and a track record of meeting or beating estimates, though its P/E remains negative at -0.27.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
Neutral
Sentiment Score
0.00
Ticker Sentiment